Comparative effectiveness research: a progress report
- PMID: 20679544
- DOI: 10.7326/0003-4819-153-7-201010050-00269
Comparative effectiveness research: a progress report
Abstract
Sixteen months ago, comparative effectiveness research (CER) began its rapid rise, when the American Recovery and Reinvestment Act of 2009 allocated $1.1 billion for CER. This progress report summarizes how the recipients of the funds-the National Institutes of Health, Agency for Healthcare Research and Quality, and Office of the Secretary of the U.S. Department of Health and Human Services-are spending the $1.1 billion, how the Institute of Medicine priority topics have fared in the agencies' funding programs, and the developing plans for a national CER program. As the United States works to absorb 32 million currently uninsured people into the health care system while simultaneously improving the quality of care and slowing cost increases, CER will increasingly be a necessary component of this change.
Similar articles
-
Comparative effectiveness research: does the emperor have clothes?Altern Ther Health Med. 2011 Mar-Apr;17(2):8-15. Altern Ther Health Med. 2011. PMID: 21717820
-
Science and the stiumulus. Medicine under the microscope.Science. 2009 Nov 27;326(5957):1183-5. doi: 10.1126/science.326.5957.1183. Science. 2009. PMID: 19965447 No abstract available.
-
How a unique provision in the American Recovery and Reinvestment Act set a foundation for the Patient-Centered Outcomes Research Institute.J Comp Eff Res. 2014 Nov;3(6):565-6. doi: 10.2217/cer.14.59. J Comp Eff Res. 2014. PMID: 25494560 No abstract available.
-
The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.Pain Physician. 2011 May-Jun;14(3):E249-82. Pain Physician. 2011. PMID: 21587337 Review.
-
Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.Pain Physician. 2010 Jan-Feb;13(1):E23-54. Pain Physician. 2010. PMID: 20119474 Review.
Cited by
-
From comparative effectiveness research to patient-centered outcomes research: integrating emergency care goals, methods, and priorities.Ann Emerg Med. 2012 Sep;60(3):309-16. doi: 10.1016/j.annemergmed.2012.03.021. Epub 2012 Apr 19. Ann Emerg Med. 2012. PMID: 22520987 Free PMC article.
-
A framework for understanding cancer comparative effectiveness research data needs.J Clin Epidemiol. 2012 Nov;65(11):1150-8. doi: 10.1016/j.jclinepi.2012.06.005. J Clin Epidemiol. 2012. PMID: 23017633 Free PMC article.
-
Comparative effectiveness research: improving patient care or drug rationing?Drugs. 2011 Mar 5;71(4):383-6. doi: 10.2165/11585410-000000000-00000. Drugs. 2011. PMID: 21395354 No abstract available.
-
Efficacy of Jian'ganle () versus Hugan Pian (), glucuronolactone and reduced glutathione in prevention of antituberculosis drug-induced liver injury.J Huazhong Univ Sci Technolog Med Sci. 2014 Jun;34(3):450-455. doi: 10.1007/s11596-014-1299-8. Epub 2014 Jun 18. J Huazhong Univ Sci Technolog Med Sci. 2014. PMID: 24939315
-
Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference.Arthritis Care Res (Hoboken). 2012 Apr;64(4):546-53. doi: 10.1002/acr.20695. Arthritis Care Res (Hoboken). 2012. PMID: 22076847 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials